Indian-origin scientists find new way to treat severe COVID-19
Wednesday, 5 August 2020 ()
A team of Indian-origin researchers has found that patients experiencing severe *COVID-19 *symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab -- used in treating autoimmune diseases like rheumatoid arthritis (RA) and other several inflammatory conditions.
The treatment...